Search

The article discusses the first buyout of a private finance initiative (PFI) contract by Northumbria Healthcare National Health Service (NHS) Foundation Trust for Hexham General Hospital, with termination completed in October 2014 and whether other NHS bodies can do the same. Topics discussed include termination costs such as financial and contractual commitment termination costs and benefits, lessons learned by NHS and challenges like lack of finances to fund PFI termination.

The article explores how the issues surrounding Bexsero, a vaccine for the serogroup B meningococcal disease, could pave the way for a change in the manner by which recommendations for new vaccines are made. Topics discussed include the production of vaccines for treating diseases that affect an individual and not a population at risk and the increasing cost of production as result of complex technology and parental concerns to adverse events that might affect their children.

The article presents arguments for and against provision of free wi-fi access by all National Health Service (NHS) premises. Topics discussed include Leeds and York Partnership NHS Foundation Trust mHabitat programme director Victoria Betton stating it helps transform health and care systems, and British Medical Association (BMA) General Practitioners Committee information technology (IT) subcommittee deputy chair Grant Ingrams believing it will affect NHS relationships with staff and patients.

The article reports that the Australian government's offer regarding 33.9m pound in funding to subsidize the humanized monoclonal antibody, eculizumab or Soliris for the treatment of atypical haemolytic uraemic syndrome (aHUS) over five years has been rejected by global drug firm Alexion.

The article reports on the government accused of using the National Health Services (NHS) as a political weapon. It mentions that health secretary of the NHS, Jeremy Hunt has made misleading claims about the role of general practitioners (GPs) in increasing pressure on overstretched accident and emergency (A&E) departments. He defended himself insisting that the problems in A&E are partly due to the ageing population, along with out-of-hours care not working properly.

The article reports that Consultant Eye Surgeons Partnership, representing 37 consultant partnerships and over 200 consultants, has been imposed a fine of 500,000 pounds by the Competition and Markets Authority, for breaches of competition law.

The article discusses the call for more investment of Great Britain to support children in early years, making reference to Rosalind Smyth, director of the Institute of Child Health at University College London who spoke at the Westminster Health Forum seminar on July 9, 2015.

The author reflects on the issues related to the implementation of the Personal Independence Payments (PIPs) in Great Britain. She explains that the goal of the benefit system is to enable the government to evaluate each individual receiving Disability Living Allowance to lessen "case load and expenditure." She further mentions that the public has expressed uncertainty over the new PIP thresholds. The author also observes the backlogs in carrying out assessments.

A letter to the editor is presented commenting on an article appearing in the January 17, 2015 issue which dealt with the quality of medical research and publishing performed in low and middle-income countries.

The article compares the cost effectiveness of giving two and three doses of human papillomavirus vaccination to girls under 15 years old. It uses data from vaccine trials and previous economic evaluations in Great Britain. The transmission model suggests that two dose is cost effective than three dose which provides young girls with protection that lasts at least 20 years.

The article compares the cost effectiveness of giving two or three doses of human papillomavirus vaccination to girls under 15 years old. It uses data from vaccine trials and previous economic evaluations in Great Britain. The transmission model suggests that the two dose is more cost effective than the three dose which provides young girls with protection that lasts at least 20 years.